Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Whitcup

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
Cellular Immunology|February 13, 2001
Skewed abrogation of tolerance to a neo self-antigen in double-transgenic mice coexpressing the antigen with interleukin-1beta or interferon-gammaM Zhang, A Fukushima, B P Vistica, et al.
American Journal of Ophthalmology|May 15, 1993
A masked, randomized, dose-response study between cyclosporine A and G in the treatment of sight-threatening uveitis of noninfectious originR B Nussenblatt, M D de Smet, B Rubin, et al.
American Journal of Ophthalmology|January 25, 1992
Retinal toxicity in human immunodeficiency virus-infected children treated with 2',3'-dideoxyinosineS M Whitcup, K M Butler, R Caruso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Phase II trial of chemotherapy alone for primary CNS and intraocular lymphomaV Sandor, V Stark-Vancs, D Pearson, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 23, 1999
Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trialR B Nussenblatt, E Fortin, R Schiffman, et al.
American Journal of Ophthalmology|May 1, 1997
Treatment of uveitis by oral administration of retinal antigens: results of a phase I/II randomized masked trialR B Nussenblatt, I Gery, H L Weiner, et al.
Investigative Ophthalmology & Visual Science|October 7, 1998
Immunotolerance against a foreign antigen transgenically expressed in the lensJ C Lai, A Fukushima, E F Wawrousek, et al.
American Journal of Ophthalmology|October 12, 2000
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panelD A Jabs, J T Rosenbaum, C S Foster, et al.
The Pediatric Infectious Disease Journal|January 6, 2001
Sino-orbital-cerebral aspergillosis in immunocompromised pediatric patientsM R Robinson, H F Fine, M L Ross, et al.
JAMA|November 30, 1999
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitisS M Whitcup, E Fortin, A S Lindblad, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Cellular Immunology|February 13, 2001
Skewed abrogation of tolerance to a neo self-antigen in double-transgenic mice coexpressing the antigen with interleukin-1beta or interferon-gammaM Zhang, A Fukushima, B P Vistica, et al.
American Journal of Ophthalmology|May 15, 1993
A masked, randomized, dose-response study between cyclosporine A and G in the treatment of sight-threatening uveitis of noninfectious originR B Nussenblatt, M D de Smet, B Rubin, et al.
American Journal of Ophthalmology|January 25, 1992
Retinal toxicity in human immunodeficiency virus-infected children treated with 2',3'-dideoxyinosineS M Whitcup, K M Butler, R Caruso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Phase II trial of chemotherapy alone for primary CNS and intraocular lymphomaV Sandor, V Stark-Vancs, D Pearson, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 23, 1999
Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trialR B Nussenblatt, E Fortin, R Schiffman, et al.
American Journal of Ophthalmology|May 1, 1997
Treatment of uveitis by oral administration of retinal antigens: results of a phase I/II randomized masked trialR B Nussenblatt, I Gery, H L Weiner, et al.
Investigative Ophthalmology & Visual Science|October 7, 1998
Immunotolerance against a foreign antigen transgenically expressed in the lensJ C Lai, A Fukushima, E F Wawrousek, et al.
American Journal of Ophthalmology|October 12, 2000
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panelD A Jabs, J T Rosenbaum, C S Foster, et al.
The Pediatric Infectious Disease Journal|January 6, 2001
Sino-orbital-cerebral aspergillosis in immunocompromised pediatric patientsM R Robinson, H F Fine, M L Ross, et al.
JAMA|November 30, 1999
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitisS M Whitcup, E Fortin, A S Lindblad, et al.
Pageof 13